Topical treatment of cutaneous metastases of malignant melanoma using combined imiquimod and 5-fluorouracil;Traitement topique des métastases cutanées de mélanome par l'association d'imiquimod et de 5-fluorouracil

Annales de Dermatologie et de Venereologie

Volumn 135, Issue 8-9, 2008, Pages 603-604

  Florin, V ^a   Vercambre Darras, S ^a   Piette, F ^a   Mortier, L ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; IMIQUIMOD; SULFADIAZINE; AMINOQUINOLINE DERIVATIVE; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; IMMUNOLOGICAL ADJUVANT;

AGED; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER REGRESSION; CASE REPORT; CLINICAL PROTOCOL; FEMALE; HUMAN; LETTER; MELANOMA; SKIN METASTASIS; SKIN NODULE; TOPICAL TREATMENT; FOLLOW UP; METASTASIS; PATHOLOGY; SKIN; SKIN TUMOR; TIME; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; AGED; AMINOQUINOLINES; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; MELANOMA; SKIN; SKIN NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 58149139411     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annder.2008.04.008     Document Type: Letter

References (9)

1. Bong A.B., Bonnekoh B., Franke I., Schön M.P., Ulrich J., and Gollnick H. Imiquimod, a topical immune response modifier, in the treatment of cutaneous metastases of malignant melanoma. Dermatology 205 (2002) 135-138
2. Steinmann A., Funk J.O., Schuler G., and von den Driesch P. Topical imiquimod treatment of a cutaneous melanoma metastasis. J Am Acad Dermatol 43 (2000) 555-556
3. Wolf I.H., Smolle J., Binder B., Cerroni L., Richtig E., and Kerl H. Topical imiquimod in the treatment of metastatic melanoma to skin. Arch Dermatol 139 (2003) 273-276
4. ®). Acta Oncol 44 (2005) 773-777
5. Ondo A.L., Mings S.M., Pestak R.M., and Shanler S.D. Topical combination therapy for cutaneous squamous cell carcinoma in situ with 5-fluorouracil cream and imiquimod cream in patients who have failed topical monotherapy. J Am Acad Dermatol 55 (2006) 1092-1094
6. Mahieu-Renard L., Richard M.A., Dales J.P., Buscaylet S., Lagrassa S., and Grob J.J. Traitement des métastases cutanées de carcinome épidermoïde de la jambe par miltéfosine en applications locales. Ann Dermatol Venereol 132 (2005) 346-348
7. Goette D.K. Topical chemotherapy with 5-fluorouracil. A review. J Am Acad Dermatol 4 (1981) 633-649
8. Wolf I.H., Cerroni L., Kodama K., and Kerl H. Treatment of lentigo maligna (melanoma in situ) with the immune response modifier imiquimod. Arch Dermatol 141 (2005) 510-514
9. Hesling C., D'Incan M., Mansard S., Franck F., Corbin-Duval A., Chèvenet C., et al. In vivo and in situ modulation of the expression of genes involved in metastasis and angiogenesis in a patient treated with topical imiquimod for melanoma skin metastases. Br J Dermatol 150 (2004) 761-767